Is GLP-1 Agonist Right for You
NICE hasn't yet published guidance on the Wegovy pill, so NHS access may change in future
The process for a biosimilar GLP-1 has several distinct stages: Development and clinical testing The manufacturer conducts analytical studies, pharmacokinetic trials, and (in some cases) clinical immunogenicity studies to demonstrate biosimilarity to the reference product BLA submission A Biologics License Application is filed with the FDA, including all comparability data FDA review Typically 12 months from filing
Who Is a Good Candidate for Weight Loss Injections
However, some individuals respond better to semaglutide due to genetic variation, making personalized testing valuable for therapy selection
GLP-1 is a hormone that helps regulate appetite and blood sugar levels, making these injections effective for weight loss